Cite

HARVARD Citation

    Martínez-Chávez, A. et al. (2022). ABCB1 and ABCG2 limit brain penetration and, together with CYP3A4, total plasma exposure of abemaciclib and its active metabolites. Pharmacological research. p. . [Online]. 
  
Back to record